Kinneir Dufort's award winning Lustre wins FDA clearance for sale in the USA

01.03.16

Ambicare Health Ltd, the developer of light-based devices for the treatment of medical and cosmetic skin conditions, announced recently that it had successfully been awarded clearance by the US Food and Drug Administration (FDA) for the over-the- counter sale of its Lustre Pure Light system

Kinneir Dufort supported Ambicare throughout the development of the Lustre system. Our integrated approach enabled the system to be developed from concept through to production backed by our single, unified team. The resulting design is unique, bringing wearable, conformable lighting technology to the consumer market.

The winning of FDA clearance is an important validation of Ambicare’s patented, wearable technology using ‘blue light’ emanating from LED’s. Unlike other devices, the acne sufferer can attach the device’s treatment heads to the affected areas and then go about his or her daily routine, rather than sitting in front of a static LED array or holding a hand-held unit, moving it from area to area. The ambulatory nature of Ambicare’s Lustre Pure Light device allows it to operate at lower, more comfortable power settings ensuring effective treatment. Lustre Pure Light has been on sale for the past year on Boots.com, in leading Boots stores and on-line. The company now intends to accelerate discussions with potential marketing partners in the United States, the world’s biggest market for acne treatment.

You can see more at:

www.lustrepurelight.com/ambicare-wins-fda-clearance-for-otc-acne-device/#sthash.G6Y6CdMk.dpuf

www.ambicarehealth.com/lustre_blog/ambicare-wins-fda-clearance-for-otc-acne-device/